Boston, MA, United States of America

Abraham LeMole

This inventor holds 1 USPTO granted patent. Top assignee: Javelin Biotech, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Abraham LeMole in Microfluidic Systems

Introduction

Abraham LeMole is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of microfluidics, particularly through his innovative designs and patents. His work focuses on developing hardware for microfluidic chips that facilitate the operation of various tissue types.

Latest Patents

LeMole holds a patent for microfluidic systems and a support module. This patent describes hardware designed for microfluidic chips, which are capable of supporting multiple tissue types, including kidney tissue, liver tissue, and adipose cells. The design of the microfluidic chips allows for controlled fluid flow through channels, ensuring that shear forces are minimized to maintain the proper flow rate. The geometry of the chambers and channels is optimized to deliver a desired amount of oxygen to sample cells or tissues in a controlled manner.

Career Highlights

Abraham LeMole is currently associated with Javelin Biotech, Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the capabilities of microfluidic technology, which has applications in various medical and research settings.

Collaborations

LeMole has collaborated with notable colleagues, including Murat Cirit and Douglas G. Sabin. These collaborations have further enhanced the development and application of microfluidic systems in research and clinical environments.

Conclusion

Abraham LeMole's contributions to microfluidic systems exemplify the intersection of innovation and biotechnology. His patent and ongoing work at Javelin Biotech, Inc. highlight the importance of advancements in this field for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…